The management of squamous cell vulval cancer: a population based retrospective study of 411 cases

Author(s): Rhodes CA, Cummins C, Shafi MI

Abstract

Objective: To audit the epidemiology, management and outcome of vulval cancer in the West Midlands.

Design: A retrospective population based study using information obtained from Cancer Intelligence Unit records.

Setting: The West Midlands Health Region.

Sample: Five hundred and six women with vulval carcinoma notified to the Cancer Intelligence Unit, during two three-year periods: 1980-1982 and 1986-1988; 411 women had a proven histological diagnosis of squamous cell carcinoma of the vulva.

Results: Histology was available for 454/506 women (90%); 411/454 women (91%) had squamous cell carcinoma: these formed the study population. The women were treated at 35 hospitals, 16 of which averaged one case or less per year. The median age at diagnosis was 74 years. Presentation was delayed by more than one year in 63/284 women with data (22%), and 97/284 cases (34%) had more than one symptom. A biopsy was taken in 268 women (65%) and surgery was the primary treatment in 344/411 cases (84%). Fifteen different operations were used. Simple vulvectomy (35%) and radical vulvectomy with bilateral inguinal lymphadenectomy (34%) were the commonest surgical procedures; 190/344 (55%) had a lymphadenectomy; of these 102 women had negative node histology and 78 women had nodal metastases, with results not recorded in 10 cases. Overall, only 46% of all women (190/411) studied had a lymphadenectomy. Recurrence was recorded in 123/411 women (30% of the total). Univariate analysis showed significantly worse five-year survival for older age, advanced stage, incomplete excision, poor differentiation, lack of lymph node resection, positive lymph node pathology and treatment in a hospital with less than 20 cases in total. A multivariate analysis using Cox proportional hazards model identified the first five factors as independent predictors of five year survival. Omission of lymphadenectomy was independently associated with poorer survival (RR 2.17, 95% CI 1.53-3.07).

Conclusions: There is wide variation in the management of vulval cancer with inadequate usage of lymphadenectomy and many centres treating few cases. Survival analysis shows prognostic variables as expected; omission of lymphadenectomy adversely affects survival.

Similar Articles

Trends in the incidence of invasive and in situ vulvar carcinoma

Author(s): Judson PL, Habermann EB, Baxter NN, Durham SB, Virnig BA

New aspects of vulvar cancer: changes in localization and age of onset

Author(s): Hampl M, Deckers-Figiel S, Hampl JA, Rein D, Bender HG

The impact of improving outcomes guidance on surgical management of vulval squamous cell cancer in southwest England (1997-2002)

Author(s): Falconer AD, Hirschowitz L, Weeks J, Murdoch J; South West Gynaecology Tumour Panel

Groin dissection practices among gynecologic oncologists treating early vulvar cancer

Author(s): Levenback C, Morris M, Burke TW, Gershenson DM, Wolf JK, et al.

A proposed glossary of terminology related to the surgical treatment of vulvar carcinoma

Author(s): Micheletti L, Preti M, Zola P, Zanotto Valentino MC, Bocci C, et al.

FIGO staging classifications and clinical practice guidelines in the management of gynecologic cancers

Author(s): Benedet JL, Bender H, Jones H 3rd, Ngan HY, Pecorelli S

Carcinoma of the vulva

Author(s): Rutledge F, Smith JP, Franklin EW

Squamous carcinoma of the vulva: results of treatment, 1938 to 1976

Author(s): Benedet JL, Turko M, Fairey RN, Boyes DA

Changing trends in the surgical treatment of invasive carcinoma of the vulva

Author(s): Cavanagh D, Roberts WS, Bryson SC, Marsden DE, Ingram JM, et al.

Management of regional lymph nodes and their prognostic influence in vulvar cancer

Author(s): Hacker NF, Berek JS, Lagasse LD, Leuchter RS, Moore JG

Squamous vulvar cancer: a clinically based individualization of treatment

Author(s): Rodolakis A, Diakomanolis E, Voulgaris Z, Akrivos T, Vlachos G, et al.

Clinical and pathological prognostic factors in squamous cell carcinoma of the vulva

Author(s): Raspagliesi F, Hanozet F, Ditto A, Solima E, Zanaboni F, et al.

Carcinoma of the vulva

Author(s): Beller U, Quinn MA, Benedet JL, Creasman WT, Ngan HY

Changes in the management of vulval cancer

Author(s): Dhar KK, Woolas RP

Individualization of treatment for stage I squamous cell vulvar carcinoma

Author(s): Hacker NF, Berek JS, Lagasse LD, Nieberg RK, Leuchter RS